Insider Transactions in Q3 2025 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2025
|
Gregory R Friberg EVP, Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,304
-7.06%
|
$178,416
$54.16 P/Share
|
|
Aug 01
2025
|
Ian T Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+50.0%
|
-
|